Medical

glucokinase

Also found in: Dictionary, Acronyms, Encyclopedia, Wikipedia.

glucokinase

 [gloo″ko-ki´nās]
an enzyme that in the presence of ATP catalyzes glucose to glucose-6-phosphate.
Miller-Keane Encyclopedia and Dictionary of Medicine, Nursing, and Allied Health, Seventh Edition. © 2003 by Saunders, an imprint of Elsevier, Inc. All rights reserved.

glu·co·ki·nase

(glū'kō-kī'nās), [MIM*138079]
Phosphotransferase that catalyzes the conversion of d-glucose and ATP to d-glucose 6-phosphate and ADP; the liver enzyme has a higher Km value for d-glucose than hexokinase and is not strongly inhibited by the product d-glucose 6-phosphate.
Farlex Partner Medical Dictionary © Farlex 2012

GCK

A gene on chromosome 7p15.3-p15.1 that encodes a glucokinase (hexokinase) that phosphorylates glucose yielding glucose-6-phosphate, the first usual step in glucose metabolism.

Molecular biology
GCK mutations are linked to type-2 diabetes, maturity-onset diabetes of the young, type 2 (MODY2) and persistent hyperinsulinemic hypoglycaemia of infancy (PHHI).
Segen's Medical Dictionary. © 2012 Farlex, Inc. All rights reserved.

glu·co·ki·nase

(glū'kō-kī'nās)
Phosphotransferase that catalyzes the conversion of d-glucose and adenosine triphosphate d-glucose 6-phosphate and adenosine diphosphate; the liver enzyme has a higher Km value for d-glucose than does hexokinase.
Medical Dictionary for the Health Professions and Nursing © Farlex 2012

glu·co·ki·nase

(glū'kō-kī'nās) [MIM*138079]
Phosphotransferase that catalyzes the conversion of d-glucose and adenosine triphosphate d-glucose 6-phosphate and adenosine diphosphate.
Medical Dictionary for the Dental Professions © Farlex 2012
Mentioned in
References in periodicals archive
Kubota et al., "Glucokinase and IRS-2 are required for compensatory [beta] cell hyperplasia in response to high-fat diet-induced insulin resistance," Journal of Clinical Investigation, vol.
If impaired beta cell regulation of [K.sub.ATP] channel activity or glucokinase activity or HNF activity was the only problem in type 2 diabetes, then its phenotype would resemble that of patients with neonatal diabetes or GCK or HNF mutations, which it does not.
Missense mutations have variable effects on glucokinase activity ranging from a small change in affinity for glucose to complete inactivity (19).
Immunodetection of glucokinase (GCK), fructokinase (FK), phosphofructokinase-2 (PFK2), and ACTINB was performed with liver homogenates from each experimental group.
Diabetic rats (group II) showed decreased activity of glucokinase and increased activity of glucose-6-phosphatase and fructose-1,6-bisphosphatase in the liver.
It is suggested that hyperglycemic effect produced is due to mobilization of glycogen in the liver which may be due to direct inhibition of glucokinase or indirectly by stimulating the release
An altered ability to sense the environment can produce hormone deficiency (e.g., glucokinase mutations producing maturity-onset diabetes of the young 2).
Under the terms of the agreement between the companies, Amgen obtained exclusive worldwide rights to Array's small-molecule glucokinase activator programme, including ARRY-403, which is currently being tested in a Phase I clinical trial in patients with type 2 diabetes.
It may reduce atherosclerotic lesions; and it modifies genomic expressions, for example, glucokinase. It is an important cofactor to several enzymes, including acetyl CoA carboxylase and other carboxylases.
Copyright © 2003-2025 Farlex, Inc Disclaimer
All content on this website, including dictionary, thesaurus, literature, geography, and other reference data is for informational purposes only. This information should not be considered complete, up to date, and is not intended to be used in place of a visit, consultation, or advice of a legal, medical, or any other professional.